Clinical trials
Hepatoblastoma trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 1 |
| GlaxoSmithKline | 1 |
| Novartis Pharmaceuticals | 1 |
| Societe Internationale d'Oncologie Pediatrique | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatoblastoma | 4 |
| Rhabdomyosarcoma | 3 |
| Neuroblastoma | 2 |
| Astrocytoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Diffuse Intrinsic Pontine Glioma | 1 |
| Ependymoma | 1 |
| Glioblastoma | 1 |
| Glioma | 1 |
| Hodgkin Disease | 1 |
Trials
Showing 26 to 4 of 4. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.